The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Polycystic Ovary Syndrome — Endocrine Management

A common endocrine disorder of hyperandrogenism and metabolic disturbance.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Internal Medicine department. Book Appointment →

What is Polycystic Ovary Syndrome — Endocrine Management?

Polycystic ovary syndrome (PCOS) is diagnosed by the Rotterdam criteria when at least two of hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology are present. It affects 6–12% of women of reproductive age.

Insulin resistance plays a central role in the pathogenesis of PCOS and is present in 50–70% of patients. The risk of metabolic syndrome, type 2 diabetes, non-alcoholic fatty liver disease and cardiovascular disease is increased. Obesity worsens the picture, but PCOS also occurs in lean women.

Treatment is individualised according to the patient's primary complaint: menstrual irregularity, hirsutism, acne or infertility. Lifestyle change is the cornerstone of treatment for all phenotypes.

Symptoms

Irregular or infrequent menstrual cycles (oligo/amenorrhoea)
Hirsutism (male-pattern facial and body hair)
Acne and oily skin
Androgenic alopecia (hair thinning)
Tendency to weight gain and insulin resistance
Infertility

Risk Factors

Family history of PCOS
Obesity (especially central obesity)
Insulin resistance
History of early puberty
Low birth weight

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • If menstrual irregularity persists for more than 3 months
  • If facial and body hair growth increases
  • If there is difficulty conceiving
  • If components of metabolic syndrome are detected

Treatment Methods

01
Lifestyle change (5–10% weight loss is already effective)
02
Combined oral contraceptives (cycle regulation and antiandrogen effect)
03
Metformin (for insulin resistance and metabolic components)
04
Spironolactone (for hirsutism and acne)
05
Letrozole or clomiphene (ovulation induction in infertility)
06
Inositol (myo-inositol + D-chiro-inositol — adjunctive)

Which Department to Visit?

You can visit our Endokrinoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Endokrinoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Thyroid Nodule Evaluation

Endokrinoloji

Thyroid nodules are very common and the vast majority are benign; however, fine-needle aspiration biopsy may be required based on ultrasound features for malignancy risk assessment.

Management of Graves' Disease

Endokrinoloji

Graves' disease is the most common cause of autoimmune hyperthyroidism, developing with excessive stimulation of the thyroid gland by thyroid-stimulating antibody (TRAb).

Management of Hashimoto's Thyroiditis

Endokrinoloji

Hashimoto's thyroiditis is the most common cause of hypothyroidism, due to autoimmune destruction of the thyroid gland with anti-TPO and anti-thyroglobulin antibodies.

Primary Adrenal Insufficiency (Addison's Disease)

Endokrinoloji

Addison's disease is a potentially life-threatening endocrine disorder presenting with cortisol and aldosterone deficiency due to autoimmune destruction of the adrenal glands.

Cushing Syndrome Diagnostic Workup

Endokrinoloji

Cushing syndrome is an endocrine disorder presenting with central obesity, striae, hypertension, and metabolic disturbances due to chronic glucocorticoid excess; its diagnosis is challenging.

Pheochromocytoma and Paraganglioma

Endokrinoloji

Pheochromocytomas and paragangliomas are rare tumors that secrete excess catecholamines, causing paroxysmal hypertension, headache, sweating, and palpitations.

Primary Hyperaldosteronism (Conn Syndrome)

Endokrinoloji

Primary hyperaldosteronism is a treatable cause of resistant hypertension and hypokalemia caused by excessive aldosterone secretion from the adrenal gland.

Comprehensive Evaluation of Hypopituitarism

Endokrinoloji

Hypopituitarism is a deficiency of pituitary hormone production that leads to multiple endocrine organ failures and requires lifelong hormone replacement.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.